icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
Efficacy and safety of MK-5172 + MK-8742± ribavirin in HCV mono-infected and HIV/HCV co-infected treatment-naïve, non-cirrhotic patients with hCV gT1 infection: The C-WORTHY study (Final results, Parts A and B)
 
 
  Reported by Jules Levin
AASLD 2014 Boston Nov 7-11
 
Mark S. Sulkowski, Christophe Hezode, Jan Gerstoft, John M. Vierling, Josep Mallolas, Stanislas Pol, Marcelo Kugelmas, Abel Murillo,
Nina Weis, Ronald Nahass, Oren Shibolet, Lawrence Serfaty, Marc Bourlière, Edwin DeJesus, Eli Zuckerman, Frank Dutko, Anita Y. M.Howe, Melissa Shaughnessy, Peggy Hwang, Janice
Wahl, Michael Robertson, Eliav Barr, Barbara Haber

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif